Medtech InsightBreast cancer is the leading cancer in women globally and incidences continue to rise. To reverse this trend, several companies are focusing their efforts on developing imaging technologies that allow
In VivoDevice Transactions The device industry pulled in $1.5 billion in financing during the second quarter of 2016, a 15% drop from Q1's $1.8 billion. Once again, debt offerings played a big role, represen
Medtech Insight2016 proved to be a slow starter for medtech IPOs with only one company pulling off an initial public offering in the first quarter. However, the public markets looked more amenable in the second quar